The DOI matches its Crossref record.
Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive Immunoprophylaxis
Open accessAbstract
Long–term immunoprophylaxis with hepatitis B immune globulin (HBIG) is widely accepted for the prevention of recurrent hepatitis B virus (HBV) infection after liver transplantation in HBV–infected patients without viral replication. We report long–term results of HBIG administration in 284 hepatitis B surface antigen (HBsAg)–positive transplant patients. In protocol 1, 259 patients were given HBIG with the goal of maintaining the anti–HBs antibody (Ab) titer over 100 IU/L. After December 1993, 25 HBV DNA–positive patients received HBIG, with a target anti–HBs Ab titer over 500 IU/L, combined with posttransplantation antiviral therapy (protocol 2). At 10 years, 44 patients without recurrence were tested for the presence of HBV DNA in serum using real–time polymerase chain reaction (PCR); 28 were also tested in liver and peripheral blood mononuclear cells (PBMC). The overall 5– and 10–year posttransplantation actuarial rates of HBV recurrence were 24.2% and 25.4%, respectively. The 5–year recurrence rate in protocol 2 patients was 11.8%. On multivariate analysis, predictors of lower HBV recurrence risk were absence of serum HBV DNA before transplantation (P < .0001), acute liver disease (P = .0037), HDV superinfection (P = .012), and protocol 2 therapy (P < .0001). Low–level HBV DNA was detected by PCR in 45.4% of patients without HBV recurrence at 10 years. Overall actuarial 10–year survival was 74.4%. In conclusion, we confirm the efficacy of long–term HBIG immunoprophylaxis. Combination prophylaxis with HBIG and antiviral therapy is effective in patients with viral replication. Although there were only a few cases of HBV recurrence after 5 years, HBV DNA remained present in 45% of patients at 10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Raimondo, G., Locarnini, S., Pollicino, T., Levrero, M., Zoulim, F., Lok, A. S., Allain, J.-P., Berg, T., Bertoletti, A., Brunetto, M. R., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.034 · Cited by 572
Self-citationGane, E. J., Angus, P. W., Strasser, S., Crawford, D. H. G., Ring, J., Jeffrey, G. P., & McCaughan, G. W. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.005 · Cited by 273
Metadata
- Authors
- Roche, B., Feray, C., Gigou, M., Roque-Afonso, A. M., Arulnaden, J. L., Delvart, V., Dussaix, E., Guettier, C., Bismuth, H., & Samuel, D.
- Venue
- Hepatology
- Published
- 2003-07
- Volume
- 38
- Issue
- 1
- Pages
- 86-95
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2010307710
- Cited by
- 229
- References
- 0
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive Immunoprophylaxis. https://app.cochat.ai/papers/10.1053/jhep.2003.50294
- The paper
- Roche, B., Feray, C., Gigou, M., Roque-Afonso, A. M., Arulnaden, J. L., Delvart, V., Dussaix, E., Guettier, C., Bismuth, H., & Samuel, D. (2003). Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive Immunoprophylaxis. Hepatology. https://doi.org/10.1053/jhep.2003.50294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.